138 related articles for article (PubMed ID: 23370671)
1. How often do level III nodes bear melanoma metastases and does it affect patient outcomes?
Nessim C; Law C; McConnell Y; Shachar S; McKinnon G; Wright F
Ann Surg Oncol; 2013 Jun; 20(6):2056-64. PubMed ID: 23370671
[TBL] [Abstract][Full Text] [Related]
2. The analysis of the outcomes and factors related to iliac-obturator involvement in cutaneous melanoma patients after lymph node dissection due to positive sentinel lymph node biopsy or clinically detected inguinal metastases.
Zdzienicki M; Rutkowski P; Nowecki ZI; van Akkooi AC; Michej W; Dziewirski W; Świtaj T; Pieńkowski A; Sałamacha M; Bylina E; Eggermont AM
Eur J Surg Oncol; 2013 Mar; 39(3):304-10. PubMed ID: 23298828
[TBL] [Abstract][Full Text] [Related]
3. Frequency of level II and III axillary nodes metastases in patients with positive sentinel lymph nodes in melanoma: a multi-institutional study in Japan.
Tsutsumida A; Takahashi A; Namikawa K; Yamazaki N; Uhara H; Teramoto Y; Takenouchi T; Fukushima S; Yokota K; Uehara J; Matsushita S; Shibayama Y; Hatta N; Masui Y; Uchi H; Fujisawa Y; Ogata D
Int J Clin Oncol; 2016 Aug; 21(4):796-800. PubMed ID: 26759315
[TBL] [Abstract][Full Text] [Related]
4. Factors predictive of pelvic lymph node involvement and outcomes in melanoma patients with metastatic sentinel lymph node of the groin: A multicentre study.
Mozzillo N; Pasquali S; Santinami M; Testori A; Di Marzo M; Crispo A; Patuzzo R; Verrecchia F; Botti G; Montella M; Rossi CR; Caracò C
Eur J Surg Oncol; 2015 Jul; 41(7):823-9. PubMed ID: 25800935
[TBL] [Abstract][Full Text] [Related]
5. Sentinel lymph node staging of cutaneous melanoma: predictors and outcomes.
Ellis MC; Weerasinghe R; Corless CL; Vetto JT
Am J Surg; 2010 May; 199(5):663-8. PubMed ID: 20466113
[TBL] [Abstract][Full Text] [Related]
6. Incidence and location of positive nonsentinel lymph nodes in head and neck melanoma.
Gyorki DE; Boyle JO; Ganly I; Morris L; Shaha AR; Singh B; Wong RJ; Shah JP; Busam K; Kraus D; Coit DG; Patel S
Eur J Surg Oncol; 2014 Mar; 40(3):305-10. PubMed ID: 24361245
[TBL] [Abstract][Full Text] [Related]
7. How many lymph nodes are enough during sentinel lymphadenectomy for primary melanoma?
Porter GA; Ross MI; Berman RS; Sumner WE; Lee JE; Mansfield PF; Gershenwald JE
Surgery; 2000 Aug; 128(2):306-11. PubMed ID: 10923009
[TBL] [Abstract][Full Text] [Related]
8. International multi-institutional management and outcome of melanoma patients with positive sentinel lymph nodes in more than one nodal basin.
Melstrom LG; Taylor E; Kuk D; Frankel TL; Panageas K; Haydu L; Sabel MS; Thompson JF; Ariyan C; Coit DG; Brady MS
Ann Surg Oncol; 2014 Dec; 21(13):4324-9. PubMed ID: 24962937
[TBL] [Abstract][Full Text] [Related]
9. Tumor-positive sentinel node biopsy of the groin in clinically node-negative melanoma patients: superficial or superficial and deep lymph node dissection?
van der Ploeg IM; Valdés Olmos RA; Kroon BB; Nieweg OE
Ann Surg Oncol; 2008 May; 15(5):1485-91. PubMed ID: 18324444
[TBL] [Abstract][Full Text] [Related]
10. Utility of Level III Axillary Node Dissection in Melanoma Patients with Palpable Axillary Lymph Node Disease.
Mahvi DA; Fairweather M; Yoon CH; Cho NL
Ann Surg Oncol; 2019 Sep; 26(9):2846-2854. PubMed ID: 31209665
[TBL] [Abstract][Full Text] [Related]
11. Lymphatic mapping and sentinel node biopsy in patients with malignant melanoma.
Reintgen D; Rapaport D; Tanabe KK; Ross M
J Fla Med Assoc; 1997 Mar; 84(3):188-93. PubMed ID: 9143171
[TBL] [Abstract][Full Text] [Related]
12. Axillary Lymph Node Metastases of Melanoma: Management of Third-level Nodes.
Gentile D; Covarelli P; Picciotto F; Caliendo V; Stingeni L; Del Sordo R; Rulli A
In Vivo; 2016; 30(2):141-5. PubMed ID: 26912825
[TBL] [Abstract][Full Text] [Related]
13. Level III axillary lymph nodes involvement in node positive breast cancer received neoadjuvant chemotherapy.
Fan Z; Li J; Wang T; Xie Y; Fan T; Lin B; Ouyang T
Breast; 2013 Dec; 22(6):1161-5. PubMed ID: 24080493
[TBL] [Abstract][Full Text] [Related]
14. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of additional positive lymph nodes in complete lymphadenectomy specimens after positive sentinel lymphadenectomy findings for early-stage melanoma of the head and neck.
Pu LL; Wells KE; Cruse CW; Shons AR; Reintgen DS
Plast Reconstr Surg; 2003 Jul; 112(1):43-9. PubMed ID: 12832875
[TBL] [Abstract][Full Text] [Related]
16. Sentinel-node biopsy or nodal observation in melanoma.
Morton DL; Thompson JF; Cochran AJ; Mozzillo N; Elashoff R; Essner R; Nieweg OE; Roses DF; Hoekstra HJ; Karakousis CP; Reintgen DS; Coventry BJ; Glass EC; Wang HJ;
N Engl J Med; 2006 Sep; 355(13):1307-17. PubMed ID: 17005948
[TBL] [Abstract][Full Text] [Related]
17. Epitrochlear sentinel lymph nodes in melanoma: interval or independent?
Kidner TB; Yoon JL; Faries MB; Morton DL
Am Surg; 2012 Jun; 78(6):702-5. PubMed ID: 22643268
[TBL] [Abstract][Full Text] [Related]
18. Desmoplastic melanoma: a 12-year experience with sentinel lymph node biopsy.
Broer PN; Walker ME; Goldberg C; Buonocore S; Braddock DT; Lazova R; Narayan D; Ariyan S
Eur J Surg Oncol; 2013 Jul; 39(7):681-5. PubMed ID: 23522951
[TBL] [Abstract][Full Text] [Related]
19. Popliteal sentinel lymph node involvement in melanoma patients.
Bertolli E; Bevilacqua JL; Molina AS; de Macedo MP; Pinto CA; Duprat Neto JP
J Surg Oncol; 2015 Aug; 112(2):179-82. PubMed ID: 26227662
[TBL] [Abstract][Full Text] [Related]
20. Reevaluation of the locoregional recurrence rate in melanoma patients with a positive sentinel node compared to patients with palpable nodal involvement.
Veenstra HJ; van der Ploeg IM; Wouters MW; Kroon BB; Nieweg OE
Ann Surg Oncol; 2010 Feb; 17(2):521-6. PubMed ID: 19898903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
